Data Foundry

Medical device recalls 2023

VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative… — Class II medical device recall Z-1628-2023

Ongoing recall by Ortho-Clinical Diagnostics, Inc., reported 2023-05-31, distributed nationwide. Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis

Recall numberZ-1628-2023
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmOrtho-Clinical Diagnostics, Inc., Raritan, NJ, United States
Recall initiated2023-04-17
Classified2023-05-24
Reported by FDA2023-05-31
DistributedNationwide (US)
Countries outside the USAU, BE, BM, BR, CA, CL, CN, CO, DE, DK, ES, FR, GB, IN, IT, JP, MX, NL, NO, PT, RU, SE, SG
Quantity23,751
UPC / GTIN / UDI-DI10758750030729
Lot numbers2023-NOV-25, 2023-SEP-02, 2024-APR-14, 2024-JAN-24, 2024-JUL-18, 2024-OCT-17, 29-9466, 30-9647, 30-9803, 31-9648, 32-9925, 33-1097, 33-1105, 33-1228

Product

VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood. Product Code: 6842905

Reason for recall

Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1628-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.